HOME >> MEDICINE >> NEWS
St. Jude unlocks mystery of very aggressive leukemia

fects in patients with CML--a finding that has revolutionized the treatment of this form of leukemia. However, imatinib has proven far less effective in treating ALL patients with the Bcr-Abl mutation, and the basis of drug resistance in this disease is unknown.

The Arf gene normally suppresses the proliferation of cells carrying cancer-causing mutations such as Bcr-Abl, according to Charles J. Sherr, M.D., Ph.D., a Howard Hughes Medical Institute investigator and co-chair of the St. Jude Department of Genetics and Tumor Cell Biology. Arf acts as a safeguard against the cancer-causing effects of Bcr-Abl, Sherr said. Sherr is senior author of the paper. The Arf gene was discovered at St. Jude in 1995 in the laboratory of Sherr and Martine F. Roussel, Ph.D., a member of the Department of Genetics and Tumor Cell Biology. Roussel is also an author of the current paper.

The St. Jude team found that Arf is not inactivated in CML patients who respond to imatinib. This is in contrast to ALL, in which Arf loss frequently occurs and imatinib treatment is far less effective. "This suggested to us that inactivation of Arf in ALL cells expressing the Bcr-Abl enzyme gives these cells a strong proliferative (cell multiplication) advantage," Sherr said. "And this advantage might contribute to imatinib resistance in some way."

To investigate this hypothesis, the researchers used a virus-like piece of DNA to carry the Bcr-Abl oncogene into bone marrow-derived lymphocytes obtained from mice that either retained Arf or were previously engineered to lack this gene. These pre-B lymphocytes represent one type of white blood cell that can become cancerous and cause ALL.

The researchers then transplanted these "transformed" cells carrying Bcr-Abl back into normal mice. Animals that received transformed pre-B cells that had both copies of the Arf gene intact were highly resistant to disease development. However, mice injected with cells that carried Bcr-Abl and lacked A
'"/>

Contact: Kelly Perry
media@stjude.org
901-495-3306
St. Jude Children's Research Hospital
19-Apr-2006


Page: 1 2 3

Related medicine news :

1. UCLA, Italian chemists move closer to solving Lou Gehrigs disease mystery
2. Radiologists attempt to solve mystery of Tuts demise
3. Solution to bacterial mystery promises new drugs
4. WA team uses baby tooth to solve death mystery
5. Old mystery solved, revealing origin of regulatory T cells that police and protect the body
6. The upstairs/downstairs mystery of cell suicide is burdened by too much evidence
7. New book explains age-old mystery of geometrical illusions
8. Differential heart-attack risks among blacks, whites remain mystery
9. Sleep-related breathing disorder common among aggressive, bullying schoolchildren
10. Genetic marker linked to aggressive prostate cancer
11. Ottawa aggressive protocol for acute atrial fibrillation is successful

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Jude unlocks mystery very aggressive leukemia

(Date:5/22/2013)... Encino, CA (PRWEB) May 22, 2013 Dr. ... alternative to painful scalpel surgery with the Laser Assisted New ... Satlin is raising awareness about the connections between gum disease ... health concerns in the United States today, and is linked ... levels of bacteria found in the infected gum pockets. ...
(Date:5/22/2013)... 22, 2013 Hosted by the California ... dental clinic provided more than $1.6 million in charitable ... in San Jose. , The California Dental Association ... to provide free dental services and oral health education ... the third clinic held by CDA and CDAF in ...
(Date:5/22/2013)... there is a gender gap when it comes to ... that does not appear to exist in children in ... levels of self-regulation than boys. Self-regulation is defined as ... directions, and persist on a task. It has been ... studies by Oregon State University researchers. , In ...
(Date:5/22/2013)... Bodybuilding.com is giving back to those ... Bodybuilding.com will be donating $1 from EVERY purchase made between ... are extremely grateful for the men and women who have ... CEO and founder of Bodybuilding.com. “It’s an honor to give ... Hire Heroes USA is an amazing organization that supports our ...
(Date:5/22/2013)... previous research that suggests umpire discrimination exists in ... between researchers at U-M and the universities of ... argument over whether MLB umpires discriminate by calling ... race. It found little statistical evidence to support ... sport management at the U-M School of Kinesiology. ...
Breaking Medicine News(10 mins):Health News:For Stroke Awareness Month, Dr. Andrew Satlin is Raising Awareness of the Connections Between Gum Disease and Stroke and Offers Encino, CA Laser Gum Surgery for Treatment 2Health News:Two-day San Jose Dental Clinic Provides More Than $1.6 Million in Care 2Health News:'Boys will be boys' in US, but not in Asia 2Health News:'Boys will be boys' in US, but not in Asia 3Health News:In the Spirit of Memorial Day, Bodybuilding.com is Donating a Portion of Their Sales to Hire Heroes 2Health News:U-M study challenges notion that umpires call more strikes for pitchers of same race 2
(Date:5/22/2013)... , May 22, 2013 Ranbaxy ... Sankyo Co., Ltd. (hereafter, Daiichi Sankyo), announced on ... in recent years to address past conduct under ... Daiichi Sankyo continues to support ... the conduct of the past which led to ...
(Date:5/22/2013)... 2013  Grifols, ein globales Unternehmen der ... , Spanien, präsentierte die Ergebnisse einer ... von PROLASTIN©-C (Alpha1-Proteinasehemmer [human]) den Spiegel des ... ein Niveau anhebt, das innerhalb des für ... ist eine lebensbedrohliche, genetische Erkrankung, bei der ...
(Date:5/22/2013)... Israel , May 22, 2013  Rosetta Genomics ... and provider of microRNA-based molecular diagnostics, announces that ... Executive Officer of Rosetta Genomics, will deliver a corporate ... from June 3-6, 2013 in New York City.  Mr. ... th at 2:00 p.m. Eastern time. ...
Breaking Medicine Technology:Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 2Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 3Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 4Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 2Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 3
Cached News: